Loading clinical trials...
Loading clinical trials...
A Randomized Phase II Trial of Paclitaxel-Carboplatin or Gemicitabine-Cisplatin in ECOG Performance Status 2 Non-Small Cell Lung Cancer Patients
Conditions
Interventions
carboplatin
cisplatin
+2 more
Locations
16
United States
Emory University Hospital - Atlanta
Atlanta, Georgia, United States
Iowa Methodist Medical Center
Des Moines, Iowa, United States
Mercy Medical Center
Des Moines, Iowa, United States
Iowa Lutheran Hospital
Des Moines, Iowa, United States
Alegent Health-Midlands Community Hospital
Papillion, Nebraska, United States
CCOP - Northern New Jersey
Hackensack, New Jersey, United States
Start Date
August 22, 2000
Primary Completion Date
January 1, 2005
Last Updated
June 15, 2023
NCT05671510
NCT07177937
NCT06043817
NCT06426511
NCT06257264
NCT06498635
Lead Sponsor
Eastern Cooperative Oncology Group
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions